Acro Biomedical (ACBM) Amortization of Deferred Charges (2022 - 2023)
Acro Biomedical's quarterly Amortization of Deferred Charges came in at $3.1 million in Q2 2023, down 20.48% year-on-year from $3.9 million in Q2 2022, and down 20.48% quarter-over-quarter from $3.9 million in Q1 2023.
Acro Biomedical has reported Amortization of Deferred Charges for 2 years, with the latest figure at $3.1 million in Q2 2023.
- For the quarter ending Q2 2023, Amortization of Deferred Charges fell 20.48% year-over-year to $3.1 million; the trailing twelve-month figure through Jun 2023 stood at $14.9 million (changed N/A YoY), and the FY2022 full-year result was $15.7 million, up 105.35% from the prior year.
- Amortization of Deferred Charges for Q2 2023 stood at $3.1 million, down from $3.9 million in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $3.9 million in Q1 2022, with the low at $3.1 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 3.12 Mn |
| Jun 30, 2023 | 3.12 Mn |
| Mar 31, 2023 | 3.93 Mn |
| Mar 31, 2023 | 3.93 Mn |
| Jun 30, 2022 | 3.93 Mn |
| Jun 30, 2022 | 3.93 Mn |
| Mar 31, 2022 | 3.93 Mn |
| Mar 31, 2022 | 3.93 Mn |